HEALWELL AI to Present at the LD Micro Main Event XVII
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, announces its participation in the 17th Annual LD Micro Main Event from October 28-30th, 2024, at the Luxe Sunset Boulevard Hotel in Los Angeles. Dr. Alexander Dobranowski, CEO of HEALWELL, will deliver a live presentation on Wednesday, October 30, 2024, at 10:30am PT and conduct in-person meetings.
Dr. Dobranowski expressed enthusiasm about sharing HEALWELL's story and showcasing their AI-driven clinical decision support systems. The event provides an opportunity to update existing shareholders and introduce the company to potential new U.S. investors. Chris Lahiji, Founder of LD Micro, emphasized the event's significance in the small and micro-cap industry.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), un'azienda tecnologica nel settore della salute focalizzata su AI e scienza dei dati per la prevenzione, annuncia la sua partecipazione al 17° evento annuale LD Micro Main Event che si terrà dal 28 al 30 ottobre 2024, presso il Luxe Sunset Boulevard Hotel a Los Angeles. Il Dr. Alexander Dobranowski, CEO di HEALWELL, terrà una presentazione dal vivo mercoledì 30 ottobre 2024, alle 10:30 PT e condurrà incontri di persona.
Il Dr. Dobranowski ha espresso entusiasmo per condividere la storia di HEALWELL e mostrare i loro sistemi di supporto decisionale clinico alimentati dall'AI. L'evento rappresenta un'opportunità per aggiornare gli attuali azionisti e introdurre l'azienda a potenziali nuovi investitori statunitensi. Chris Lahiji, fondatore di LD Micro, ha sottolineato l'importanza dell'evento nell'industria delle piccole e micro-cap.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), una empresa de tecnología en el sector de la salud centrada en IA y ciencia de datos para el cuidado preventivo, anuncia su participación en el 17° Evento Anual LD Micro Main Event del 28 al 30 de octubre de 2024, en el Luxe Sunset Boulevard Hotel de Los Ángeles. El Dr. Alexander Dobranowski, CEO de HEALWELL, realizará una presentación en vivo el miércoles 30 de octubre de 2024, a las 10:30 am PT y llevará a cabo reuniones en persona.
El Dr. Dobranowski expresó su entusiasmo por compartir la historia de HEALWELL y mostrar sus sistemas de apoyo a la decisión clínica impulsados por IA. El evento brinda una oportunidad para actualizar a los accionistas existentes e introducir la empresa a nuevos inversores potenciales de EE. UU. Chris Lahiji, fundador de LD Micro, enfatizó la importancia del evento en la industria de pequeñas y micro empresas.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF)는 예방 치료를 위한 AI 및 데이터 과학에 초점을 맞춘 헬스케어 기술 회사로, 2024년 10월 28일부터 30일까지 로스앤젤레스의 Luxe Sunset Boulevard Hotel에서 열리는 제17회 LD Micro 메인 이벤트에 참여한다고 발표했습니다. HEALWELL의 CEO인 Alexander Dobranowski 박사는 2024년 10월 30일 수요일 오전 10시 30분 PT에 실시간 발표를 할 것이며, 대면 회의도 진행할 예정입니다.
Dobranowski 박사는 HEALWELL의 이야기를 나누고 AI 기반 임상 의사 결정 지원 시스템을 소개할 수 있게 되어 기쁘다고 표현했습니다. 이번 행사는 기존 주주에게 업데이트를 제공하고 미국의 잠재적 신규 투자자에게 회사를 소개할 기회를 제공합니다. LD Micro의 창립자 Chris Lahiji는 이 행사의 소규모 및 마이크로 캡 산업에서의 중요성을 강조했습니다.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), une entreprise de technologie de la santé axée sur l'IA et la science des données pour les soins préventifs, annonce sa participation au 17ème événement annuel LD Micro Main Event qui se déroulera du 28 au 30 octobre 2024, à l'hôtel Luxe Sunset Boulevard à Los Angeles. Le Dr. Alexander Dobranowski, PDG de HEALWELL, fera une présentation en direct le mercredi 30 octobre 2024 à 10 h 30 PT et tiendra des réunions en personne.
Le Dr. Dobranowski a exprimé son enthousiasme à partager l'histoire de HEALWELL et à présenter leurs systèmes de soutien à la décision clinique alimentés par l'IA. L'événement offre une occasion de mettre à jour les actionnaires existants et d'introduire l'entreprise à de nouveaux investisseurs potentiels aux États-Unis. Chris Lahiji, fondateur de LD Micro, a souligné l'importance de l'événement dans l'industrie des petites et micro-capitalisations.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), ein Technologieunternehmen im Gesundheitswesen, das sich auf KI und Datenwissenschaft für präventive Pflege konzentriert, kündigt seine Teilnahme am 17. jährlichen LD Micro Main Event vom 28. bis 30. Oktober 2024 im Luxe Sunset Boulevard Hotel in Los Angeles an. Dr. Alexander Dobranowski, CEO von HEALWELL, wird am 30. Oktober 2024, um 10:30 Uhr PT eine Live-Präsentation halten und persönliche Meetings durchführen.
Dr. Dobranowski äußerte Begeisterung darüber, die Geschichte von HEALWELL zu teilen und deren KI-gesteuerte klinische Entscheidungsunterstützungssysteme vorzustellen. Die Veranstaltung bietet die Möglichkeit, bestehende Aktionäre zu informieren und das Unternehmen potenziellen neuen Investoren in den USA vorzustellen. Chris Lahiji, Gründer von LD Micro, betonte die Bedeutung der Veranstaltung in der kleinen und mikro-kapitalisierten Branche.
- Participation in a prominent investor event (LD Micro Main Event XVII) potentially increasing visibility
- Opportunity to showcase AI-driven healthcare solutions to a wider investor audience
- Potential to attract new U.S. investors through in-person meetings and presentations
- None.
- Participating in-person at the LD Micro Main Event XVII from October 28-30th at the Luxe Sunset Boulevard Hotel in Los Angeles
Toronto, Ontario--(Newsfile Corp. - October 18, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL, will be participating at the 17th Annual LD Micro Main Event taking place at the Luxe Sunset Boulevard Hotel in Los Angeles from October 28-30th, 2024. Dr. Dobranowski will be providing a live presentation on Wednesday, October 30, 2024 at 10:30am PT (1:30pm ET), and will be conducting in-person 1on1 meetings at the conference venue.
LD Micro Main Event XVII
Presentation Date: Wednesday, October 30th
Presentation Time: 10:30 am PT - Track #2
Register to watch the virtual presentation here.
Dr. Alexander Dobranowski, CEO of HEALWELL AI, commented, "We are thrilled to be participating in the LD Micro Main Event, a great opportunity to share the HEALWELL story and how we are revolutionizing healthcare through our AI-driven clinical decision support systems. Engaging with the investment community at events like this allows us to showcase the strides we are making in healthcare tech as well as the impact of our innovative solutions on a global level. We are excited to share HEALWELL's future growth trajectory and provide an update to existing shareholders as well as introduce the company to potential new investors in the U.S."
Chris Lahiji, Founder of LD Micro, shared, "We understand the significance of this event for our industry and the enthusiasm it generates among attendees. We're grateful to the leaders at our parent company, Freedom, for their strong alignment with our vision. Our conference is more than just meetings and presentations-it's about laying the groundwork for the future and establishing it as the essential event in small and micro-cap that no one can miss. I'm truly honored to welcome our valued friends and partners to the seventeenth edition of the Main Event."
About LD Micro
LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Through the LD Micro Index and annual investor conferences, LD has served as an invaluable asset to all those interested in discovering the next generation of great companies. For more information on LD Micro, visit www.ldmicro.com. To present or register, please contact registration@ldmicro.com.
About HEALWELL AI
HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the "TSX") under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
For additional Information, please contact:
Pardeep Sangha
Investor Relations
604-572-6392
ir@healwell.ai
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/227041
FAQ
When and where is HEALWELL AI (HWAIF) presenting at the LD Micro Main Event XVII?
What is the focus of HEALWELL AI's (HWAIF) presentation at the LD Micro Main Event?
How can investors watch HEALWELL AI's (HWAIF) presentation at the LD Micro Main Event?